Intranasal Chlorpheniramine for Early Symptomatic Treatment of COVID-19 and the Impact on Long-COVID

Gustavo Ferrer • Fernando Valerio-Pascua • César Alas-Pineda • et.al., DOI: 10.7759/cureus.82736  Abstract This review explores the therapeutic potential of intranasal chlorpheniramine maleate (iCPM) in managing both acute COVID-19 and Long COVID by integrating histamine H1 receptor […]

Treatment on Trial to Reverse Long COVID Effects

The NIH-funded trial will determine if immunomodulation can improve brain and cardiovascular dysfunction. An immunomodulator being investigated by researchers at Vanderbilt University Medical Center holds promise in reversing the effects […]